PHI preferentially binds to VIP receptors in normal rat tissues

¹Department of Medicine, University of Calgary, Alberta, Canada.

|September 1, 1990

Abstract:

Vasoactive intestinal peptide (VIP) and peptide histidine isoleucine (PHI) are homologous neuropeptides with parallel biological actions. These similarities raise the question whether VIP and PHI have common or distinct mechanisms of action, including receptors. The present study attempted to distinguish specific binding sites for VIP and PHI in normal rat tissues using the homologous radioligands [Tyr(125I)10]VIP and [Tyr(125I)10]rat PHI. In rat brain, anterior pituitary, and liver membranes both radioligands identified a VIP-preferring receptor. Rat PHI had less than 10% the binding potency of VIP in these tissues irrespective of which radioligand was used. In rat uterine membranes [Tyr(125I)10]VIP bound to a receptor with approximately 100 times greater affinity for VIP over PHI. No specific binding of [Tyr(125I)10]rat PHI to rat uterus could be demonstrated. In conclusion, these results support the predominance of VIP-preferring receptors as opposed to PHI-preferring receptors in normal rat brain, anterior pituitary, liver and uterus.

Related Experiment Videos

PHI preferentially binds to VIP receptors in normal rat tissues

Related Concept Videos

Assessments of Coronary Artery Visibility and Radiation Dose in Infants with Congenital Heart Disease on Cardiac 128-slice CT and on Cardiac 64-slice CT.

Comparison of tacrolimus and cyclosporin A in CYP3A5 expressing Chinese de novo kidney transplant recipients: a 2-year prospective study.

Atmospheric benzenoid emissions from plants rival those from fossil fuels.

Measurement of pion, kaon and proton production in proton-proton collisions at [Formula: see text] TeV.

Production of [Formula: see text] and [Formula: see text] in proton-proton collisions at [Formula: see text] 7 TeV.

Measurement of inelastic, single- and double-diffraction cross sections in proton-proton collisions at the LHC with ALICE.

In Vitro Chondrogenic Differentiation is Improved by the BMP7-Derived Peptide p[63-82].

Advances in Weight-Loss-Independent Cardiovascular Protective Mechanisms of GLP-1 Receptor Agonists.

Erythropoietin-derived peptide (HBSP) inhibits caspase-3/GSDME through HMGB1 to regulate pyroptosis and reduce diabetic retinopathy.

IGF2BP3 drives macrophage M1 polarization to promote intracranial aneurysm rupture through m6A-mediated NPY1R stabilization.

Galanin signaling in stress-induced brain-gut axis dysregulation: Receptor-specific mechanisms and context-dependent pharmacology.

KR-36996, an orally active urotensin II receptor antagonist, attenuates hepatic inflammation and fibrosis in methionine- and choline-deficient diet-induced fibrosing steatohepatitis.

Biochemical characteristics associated with spironolactone use in hospitalized patients with hypotonic hyponatraemia.

The safety and efficacy of drug-coated balloon dilation system (Keeway) for benign prostate hyperplasia: a preclinical study.

Pharmacokinetics, mass balance, and metabolism of [14C]SPH3127 (sitokiren), a novel direct renin inhibitor in humans.

Effect of Sodium C-Tetra(propyl)resorcin[4]tetrasulfonate (Na4PRA) on Antituberculosis Drugs as Seen by Diffusometry and NMR Spectroscopy.

Preclinical Pharmacokinetic and Pharmacological Profiling of B339, a Novel SARM1 Inhibitor for the Treatment of Vincristine-induced Peripheral Neuropathy.

Pharmacodynamics of Boronic Acids and Boronates.

Related Experiment Videos

PHI preferentially binds to VIP receptors in normal rat tissues

Abstract:

Related Concept Videos

Related Articles